Loading…

TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes

Human hepatocytes usually are resistant to TNF-alpha cytotoxicity. In mouse or rat hepatocytes, repression of NF-kappaB activation is sufficient to induce TNF-alpha-mediated apoptosis. However, in both Huh-7 human hepatoma cells and Hc human normal hepatocytes, when infected with an adenovirus expre...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of immunology (1950) 2001-07, Vol.167 (1), p.173-180
Main Authors: Osawa, Y, Banno, Y, Nagaki, M, Brenner, D A, Naiki, T, Nozawa, Y, Nakashima, S, Moriwaki, H
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c374t-ea6fc3390aa393b8fef64f61386098ac14f718335299e4b0629bde02b73491053
cites cdi_FETCH-LOGICAL-c374t-ea6fc3390aa393b8fef64f61386098ac14f718335299e4b0629bde02b73491053
container_end_page 180
container_issue 1
container_start_page 173
container_title The Journal of immunology (1950)
container_volume 167
creator Osawa, Y
Banno, Y
Nagaki, M
Brenner, D A
Naiki, T
Nozawa, Y
Nakashima, S
Moriwaki, H
description Human hepatocytes usually are resistant to TNF-alpha cytotoxicity. In mouse or rat hepatocytes, repression of NF-kappaB activation is sufficient to induce TNF-alpha-mediated apoptosis. However, in both Huh-7 human hepatoma cells and Hc human normal hepatocytes, when infected with an adenovirus expressing a mutated form of IkappaBalpha (Ad5IkappaB), which almost completely blocks NF-kappaB activation, >80% of the cells survived 24 h after TNF-alpha stimulation. Here, we report that TNF-alpha activates other antiapoptotic factors, such as sphingosine kinase (SphK), phosphatidylinositol 3-kinase (PI3K), and Akt kinase. Pretreatment of cells with N,N-dimethylsphingosine (DMS), an inhibitor of SphK, or LY 294002, an inhibitor of PI3K that acts upstream of Akt, increased the number of apoptotic cells induced by TNF-alpha in Ad5IkappaB-infected Huh-7 and Hc cells. TNF-alpha-induced activations of PI3K and Akt were inhibited by DMS. In contrast, exogenous sphingosine 1-phosphate, a product of SphK, was found to activate Akt and partially rescued the cells from TNF-alpha-induced apoptosis. Although Akt has been reported to activate NF-kappaB, DMS and LY 294002 failed to prevent TNF-alpha-induced NF-kappaB activation, suggesting that the antiapoptotic effects of SphK and Akt are independent of NF-kappaB. Furthermore, apoptosis mediated by Fas ligand (FasL) involving Akt activation also was potentiated by DMS pretreatment in Hc cells. Sphingosine 1-phosphate administration partially protected cells from FasL-mediated apoptosis. These results indicate that not only NF-kappaB but also SphK and PI3K/Akt are involved in the signaling pathway(s) for protection of human hepatocytes from the apoptotic action of TNF-alpha and probably FasL.
doi_str_mv 10.4049/jimmunol.167.1.173
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70974933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70974933</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-ea6fc3390aa393b8fef64f61386098ac14f718335299e4b0629bde02b73491053</originalsourceid><addsrcrecordid>eNqFkTtOxDAQhi0EguVxAQrkis7LTOy14xIhFpAQNFBHTuIQQxKH2BHaA3BvjFhESTMj_a_mI-QUYSlA6ItX1_fz4LslSrXEJSq-Qxa4WgGTEuQuWQBkGUMl1QE5DOEVACRkYp8cIArMpZAL8vn0sGamG1vD3FDPla1pGFs3vPjgBkuRja1PgomWuqF1pYuBmtGPMfmBxnby80tLDf2NuXrTuSGZ0XeUszc3mGAvLt8iHU1sP8wmzdB27k26Nkm-2kQbjsleY7pgT7b_iDyvr5-ubtn9483d1eU9q7gSkVkjm4pzDcZwzcu8sY0UjUSeS9C5qVA0CnPOV5nWVpQgM13WFrJScaERVvyInP_sjpN_n22IRe9CZbvODNbPoVCgldCc_xtElWvMEFIw-wlWkw9hsk0xTq4306ZAKL4pFb-UikSpwNT8Xj_brs9lb-u_yhYL_wIxjZKP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17891210</pqid></control><display><type>article</type><title>TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Osawa, Y ; Banno, Y ; Nagaki, M ; Brenner, D A ; Naiki, T ; Nozawa, Y ; Nakashima, S ; Moriwaki, H</creator><creatorcontrib>Osawa, Y ; Banno, Y ; Nagaki, M ; Brenner, D A ; Naiki, T ; Nozawa, Y ; Nakashima, S ; Moriwaki, H</creatorcontrib><description>Human hepatocytes usually are resistant to TNF-alpha cytotoxicity. In mouse or rat hepatocytes, repression of NF-kappaB activation is sufficient to induce TNF-alpha-mediated apoptosis. However, in both Huh-7 human hepatoma cells and Hc human normal hepatocytes, when infected with an adenovirus expressing a mutated form of IkappaBalpha (Ad5IkappaB), which almost completely blocks NF-kappaB activation, &gt;80% of the cells survived 24 h after TNF-alpha stimulation. Here, we report that TNF-alpha activates other antiapoptotic factors, such as sphingosine kinase (SphK), phosphatidylinositol 3-kinase (PI3K), and Akt kinase. Pretreatment of cells with N,N-dimethylsphingosine (DMS), an inhibitor of SphK, or LY 294002, an inhibitor of PI3K that acts upstream of Akt, increased the number of apoptotic cells induced by TNF-alpha in Ad5IkappaB-infected Huh-7 and Hc cells. TNF-alpha-induced activations of PI3K and Akt were inhibited by DMS. In contrast, exogenous sphingosine 1-phosphate, a product of SphK, was found to activate Akt and partially rescued the cells from TNF-alpha-induced apoptosis. Although Akt has been reported to activate NF-kappaB, DMS and LY 294002 failed to prevent TNF-alpha-induced NF-kappaB activation, suggesting that the antiapoptotic effects of SphK and Akt are independent of NF-kappaB. Furthermore, apoptosis mediated by Fas ligand (FasL) involving Akt activation also was potentiated by DMS pretreatment in Hc cells. Sphingosine 1-phosphate administration partially protected cells from FasL-mediated apoptosis. These results indicate that not only NF-kappaB but also SphK and PI3K/Akt are involved in the signaling pathway(s) for protection of human hepatocytes from the apoptotic action of TNF-alpha and probably FasL.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.167.1.173</identifier><identifier>PMID: 11418646</identifier><language>eng</language><publisher>United States</publisher><subject><![CDATA[Adenoviridae - genetics ; Adjuvants, Immunologic - antagonists & inhibitors ; Adjuvants, Immunologic - pharmacology ; Akt protein ; Apoptosis - genetics ; Apoptosis - immunology ; Caspases - metabolism ; Cell Line ; DNA Fragmentation - immunology ; Enzyme Activation - genetics ; Enzyme Activation - immunology ; Fas Ligand Protein ; fas Receptor - metabolism ; FasL protein ; Hepatocytes - cytology ; Hepatocytes - enzymology ; Hepatocytes - immunology ; Hepatocytes - virology ; Humans ; I-kappa B Proteins - genetics ; Ligands ; Lysophospholipids ; Membrane Glycoproteins - antagonists & inhibitors ; Membrane Glycoproteins - pharmacology ; NF-kappa B - antagonists & inhibitors ; NF-kappa B - metabolism ; Phosphatidylinositol 3-Kinases - antagonists & inhibitors ; Phosphatidylinositol 3-Kinases - physiology ; Phosphotransferases (Alcohol Group Acceptor) - antagonists & inhibitors ; Phosphotransferases (Alcohol Group Acceptor) - metabolism ; Protein-Serine-Threonine Kinases - antagonists & inhibitors ; Protein-Serine-Threonine Kinases - physiology ; Proto-Oncogene Proteins - antagonists & inhibitors ; Proto-Oncogene Proteins - physiology ; Proto-Oncogene Proteins c-akt ; Signal Transduction - genetics ; Signal Transduction - immunology ; Sphingosine - analogs & derivatives ; Sphingosine - biosynthesis ; Sphingosine - immunology ; Sphingosine - metabolism ; Sphingosine - pharmacology ; sphingosine kinase ; Tumor Cells, Cultured ; Tumor Necrosis Factor-alpha - pharmacology]]></subject><ispartof>The Journal of immunology (1950), 2001-07, Vol.167 (1), p.173-180</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c374t-ea6fc3390aa393b8fef64f61386098ac14f718335299e4b0629bde02b73491053</citedby><cites>FETCH-LOGICAL-c374t-ea6fc3390aa393b8fef64f61386098ac14f718335299e4b0629bde02b73491053</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11418646$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Osawa, Y</creatorcontrib><creatorcontrib>Banno, Y</creatorcontrib><creatorcontrib>Nagaki, M</creatorcontrib><creatorcontrib>Brenner, D A</creatorcontrib><creatorcontrib>Naiki, T</creatorcontrib><creatorcontrib>Nozawa, Y</creatorcontrib><creatorcontrib>Nakashima, S</creatorcontrib><creatorcontrib>Moriwaki, H</creatorcontrib><title>TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>Human hepatocytes usually are resistant to TNF-alpha cytotoxicity. In mouse or rat hepatocytes, repression of NF-kappaB activation is sufficient to induce TNF-alpha-mediated apoptosis. However, in both Huh-7 human hepatoma cells and Hc human normal hepatocytes, when infected with an adenovirus expressing a mutated form of IkappaBalpha (Ad5IkappaB), which almost completely blocks NF-kappaB activation, &gt;80% of the cells survived 24 h after TNF-alpha stimulation. Here, we report that TNF-alpha activates other antiapoptotic factors, such as sphingosine kinase (SphK), phosphatidylinositol 3-kinase (PI3K), and Akt kinase. Pretreatment of cells with N,N-dimethylsphingosine (DMS), an inhibitor of SphK, or LY 294002, an inhibitor of PI3K that acts upstream of Akt, increased the number of apoptotic cells induced by TNF-alpha in Ad5IkappaB-infected Huh-7 and Hc cells. TNF-alpha-induced activations of PI3K and Akt were inhibited by DMS. In contrast, exogenous sphingosine 1-phosphate, a product of SphK, was found to activate Akt and partially rescued the cells from TNF-alpha-induced apoptosis. Although Akt has been reported to activate NF-kappaB, DMS and LY 294002 failed to prevent TNF-alpha-induced NF-kappaB activation, suggesting that the antiapoptotic effects of SphK and Akt are independent of NF-kappaB. Furthermore, apoptosis mediated by Fas ligand (FasL) involving Akt activation also was potentiated by DMS pretreatment in Hc cells. Sphingosine 1-phosphate administration partially protected cells from FasL-mediated apoptosis. These results indicate that not only NF-kappaB but also SphK and PI3K/Akt are involved in the signaling pathway(s) for protection of human hepatocytes from the apoptotic action of TNF-alpha and probably FasL.</description><subject>Adenoviridae - genetics</subject><subject>Adjuvants, Immunologic - antagonists &amp; inhibitors</subject><subject>Adjuvants, Immunologic - pharmacology</subject><subject>Akt protein</subject><subject>Apoptosis - genetics</subject><subject>Apoptosis - immunology</subject><subject>Caspases - metabolism</subject><subject>Cell Line</subject><subject>DNA Fragmentation - immunology</subject><subject>Enzyme Activation - genetics</subject><subject>Enzyme Activation - immunology</subject><subject>Fas Ligand Protein</subject><subject>fas Receptor - metabolism</subject><subject>FasL protein</subject><subject>Hepatocytes - cytology</subject><subject>Hepatocytes - enzymology</subject><subject>Hepatocytes - immunology</subject><subject>Hepatocytes - virology</subject><subject>Humans</subject><subject>I-kappa B Proteins - genetics</subject><subject>Ligands</subject><subject>Lysophospholipids</subject><subject>Membrane Glycoproteins - antagonists &amp; inhibitors</subject><subject>Membrane Glycoproteins - pharmacology</subject><subject>NF-kappa B - antagonists &amp; inhibitors</subject><subject>NF-kappa B - metabolism</subject><subject>Phosphatidylinositol 3-Kinases - antagonists &amp; inhibitors</subject><subject>Phosphatidylinositol 3-Kinases - physiology</subject><subject>Phosphotransferases (Alcohol Group Acceptor) - antagonists &amp; inhibitors</subject><subject>Phosphotransferases (Alcohol Group Acceptor) - metabolism</subject><subject>Protein-Serine-Threonine Kinases - antagonists &amp; inhibitors</subject><subject>Protein-Serine-Threonine Kinases - physiology</subject><subject>Proto-Oncogene Proteins - antagonists &amp; inhibitors</subject><subject>Proto-Oncogene Proteins - physiology</subject><subject>Proto-Oncogene Proteins c-akt</subject><subject>Signal Transduction - genetics</subject><subject>Signal Transduction - immunology</subject><subject>Sphingosine - analogs &amp; derivatives</subject><subject>Sphingosine - biosynthesis</subject><subject>Sphingosine - immunology</subject><subject>Sphingosine - metabolism</subject><subject>Sphingosine - pharmacology</subject><subject>sphingosine kinase</subject><subject>Tumor Cells, Cultured</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkTtOxDAQhi0EguVxAQrkis7LTOy14xIhFpAQNFBHTuIQQxKH2BHaA3BvjFhESTMj_a_mI-QUYSlA6ItX1_fz4LslSrXEJSq-Qxa4WgGTEuQuWQBkGUMl1QE5DOEVACRkYp8cIArMpZAL8vn0sGamG1vD3FDPla1pGFs3vPjgBkuRja1PgomWuqF1pYuBmtGPMfmBxnby80tLDf2NuXrTuSGZ0XeUszc3mGAvLt8iHU1sP8wmzdB27k26Nkm-2kQbjsleY7pgT7b_iDyvr5-ubtn9483d1eU9q7gSkVkjm4pzDcZwzcu8sY0UjUSeS9C5qVA0CnPOV5nWVpQgM13WFrJScaERVvyInP_sjpN_n22IRe9CZbvODNbPoVCgldCc_xtElWvMEFIw-wlWkw9hsk0xTq4306ZAKL4pFb-UikSpwNT8Xj_brs9lb-u_yhYL_wIxjZKP</recordid><startdate>20010701</startdate><enddate>20010701</enddate><creator>Osawa, Y</creator><creator>Banno, Y</creator><creator>Nagaki, M</creator><creator>Brenner, D A</creator><creator>Naiki, T</creator><creator>Nozawa, Y</creator><creator>Nakashima, S</creator><creator>Moriwaki, H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20010701</creationdate><title>TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes</title><author>Osawa, Y ; Banno, Y ; Nagaki, M ; Brenner, D A ; Naiki, T ; Nozawa, Y ; Nakashima, S ; Moriwaki, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-ea6fc3390aa393b8fef64f61386098ac14f718335299e4b0629bde02b73491053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adenoviridae - genetics</topic><topic>Adjuvants, Immunologic - antagonists &amp; inhibitors</topic><topic>Adjuvants, Immunologic - pharmacology</topic><topic>Akt protein</topic><topic>Apoptosis - genetics</topic><topic>Apoptosis - immunology</topic><topic>Caspases - metabolism</topic><topic>Cell Line</topic><topic>DNA Fragmentation - immunology</topic><topic>Enzyme Activation - genetics</topic><topic>Enzyme Activation - immunology</topic><topic>Fas Ligand Protein</topic><topic>fas Receptor - metabolism</topic><topic>FasL protein</topic><topic>Hepatocytes - cytology</topic><topic>Hepatocytes - enzymology</topic><topic>Hepatocytes - immunology</topic><topic>Hepatocytes - virology</topic><topic>Humans</topic><topic>I-kappa B Proteins - genetics</topic><topic>Ligands</topic><topic>Lysophospholipids</topic><topic>Membrane Glycoproteins - antagonists &amp; inhibitors</topic><topic>Membrane Glycoproteins - pharmacology</topic><topic>NF-kappa B - antagonists &amp; inhibitors</topic><topic>NF-kappa B - metabolism</topic><topic>Phosphatidylinositol 3-Kinases - antagonists &amp; inhibitors</topic><topic>Phosphatidylinositol 3-Kinases - physiology</topic><topic>Phosphotransferases (Alcohol Group Acceptor) - antagonists &amp; inhibitors</topic><topic>Phosphotransferases (Alcohol Group Acceptor) - metabolism</topic><topic>Protein-Serine-Threonine Kinases - antagonists &amp; inhibitors</topic><topic>Protein-Serine-Threonine Kinases - physiology</topic><topic>Proto-Oncogene Proteins - antagonists &amp; inhibitors</topic><topic>Proto-Oncogene Proteins - physiology</topic><topic>Proto-Oncogene Proteins c-akt</topic><topic>Signal Transduction - genetics</topic><topic>Signal Transduction - immunology</topic><topic>Sphingosine - analogs &amp; derivatives</topic><topic>Sphingosine - biosynthesis</topic><topic>Sphingosine - immunology</topic><topic>Sphingosine - metabolism</topic><topic>Sphingosine - pharmacology</topic><topic>sphingosine kinase</topic><topic>Tumor Cells, Cultured</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Osawa, Y</creatorcontrib><creatorcontrib>Banno, Y</creatorcontrib><creatorcontrib>Nagaki, M</creatorcontrib><creatorcontrib>Brenner, D A</creatorcontrib><creatorcontrib>Naiki, T</creatorcontrib><creatorcontrib>Nozawa, Y</creatorcontrib><creatorcontrib>Nakashima, S</creatorcontrib><creatorcontrib>Moriwaki, H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Osawa, Y</au><au>Banno, Y</au><au>Nagaki, M</au><au>Brenner, D A</au><au>Naiki, T</au><au>Nozawa, Y</au><au>Nakashima, S</au><au>Moriwaki, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>2001-07-01</date><risdate>2001</risdate><volume>167</volume><issue>1</issue><spage>173</spage><epage>180</epage><pages>173-180</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>Human hepatocytes usually are resistant to TNF-alpha cytotoxicity. In mouse or rat hepatocytes, repression of NF-kappaB activation is sufficient to induce TNF-alpha-mediated apoptosis. However, in both Huh-7 human hepatoma cells and Hc human normal hepatocytes, when infected with an adenovirus expressing a mutated form of IkappaBalpha (Ad5IkappaB), which almost completely blocks NF-kappaB activation, &gt;80% of the cells survived 24 h after TNF-alpha stimulation. Here, we report that TNF-alpha activates other antiapoptotic factors, such as sphingosine kinase (SphK), phosphatidylinositol 3-kinase (PI3K), and Akt kinase. Pretreatment of cells with N,N-dimethylsphingosine (DMS), an inhibitor of SphK, or LY 294002, an inhibitor of PI3K that acts upstream of Akt, increased the number of apoptotic cells induced by TNF-alpha in Ad5IkappaB-infected Huh-7 and Hc cells. TNF-alpha-induced activations of PI3K and Akt were inhibited by DMS. In contrast, exogenous sphingosine 1-phosphate, a product of SphK, was found to activate Akt and partially rescued the cells from TNF-alpha-induced apoptosis. Although Akt has been reported to activate NF-kappaB, DMS and LY 294002 failed to prevent TNF-alpha-induced NF-kappaB activation, suggesting that the antiapoptotic effects of SphK and Akt are independent of NF-kappaB. Furthermore, apoptosis mediated by Fas ligand (FasL) involving Akt activation also was potentiated by DMS pretreatment in Hc cells. Sphingosine 1-phosphate administration partially protected cells from FasL-mediated apoptosis. These results indicate that not only NF-kappaB but also SphK and PI3K/Akt are involved in the signaling pathway(s) for protection of human hepatocytes from the apoptotic action of TNF-alpha and probably FasL.</abstract><cop>United States</cop><pmid>11418646</pmid><doi>10.4049/jimmunol.167.1.173</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof The Journal of immunology (1950), 2001-07, Vol.167 (1), p.173-180
issn 0022-1767
1550-6606
language eng
recordid cdi_proquest_miscellaneous_70974933
source EZB-FREE-00999 freely available EZB journals
subjects Adenoviridae - genetics
Adjuvants, Immunologic - antagonists & inhibitors
Adjuvants, Immunologic - pharmacology
Akt protein
Apoptosis - genetics
Apoptosis - immunology
Caspases - metabolism
Cell Line
DNA Fragmentation - immunology
Enzyme Activation - genetics
Enzyme Activation - immunology
Fas Ligand Protein
fas Receptor - metabolism
FasL protein
Hepatocytes - cytology
Hepatocytes - enzymology
Hepatocytes - immunology
Hepatocytes - virology
Humans
I-kappa B Proteins - genetics
Ligands
Lysophospholipids
Membrane Glycoproteins - antagonists & inhibitors
Membrane Glycoproteins - pharmacology
NF-kappa B - antagonists & inhibitors
NF-kappa B - metabolism
Phosphatidylinositol 3-Kinases - antagonists & inhibitors
Phosphatidylinositol 3-Kinases - physiology
Phosphotransferases (Alcohol Group Acceptor) - antagonists & inhibitors
Phosphotransferases (Alcohol Group Acceptor) - metabolism
Protein-Serine-Threonine Kinases - antagonists & inhibitors
Protein-Serine-Threonine Kinases - physiology
Proto-Oncogene Proteins - antagonists & inhibitors
Proto-Oncogene Proteins - physiology
Proto-Oncogene Proteins c-akt
Signal Transduction - genetics
Signal Transduction - immunology
Sphingosine - analogs & derivatives
Sphingosine - biosynthesis
Sphingosine - immunology
Sphingosine - metabolism
Sphingosine - pharmacology
sphingosine kinase
Tumor Cells, Cultured
Tumor Necrosis Factor-alpha - pharmacology
title TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A24%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TNF-alpha-induced%20sphingosine%201-phosphate%20inhibits%20apoptosis%20through%20a%20phosphatidylinositol%203-kinase/Akt%20pathway%20in%20human%20hepatocytes&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Osawa,%20Y&rft.date=2001-07-01&rft.volume=167&rft.issue=1&rft.spage=173&rft.epage=180&rft.pages=173-180&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.167.1.173&rft_dat=%3Cproquest_cross%3E70974933%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c374t-ea6fc3390aa393b8fef64f61386098ac14f718335299e4b0629bde02b73491053%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17891210&rft_id=info:pmid/11418646&rfr_iscdi=true